These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 11563046)
1. Ribose modified nucleosides and nucleotides as ligands for purine receptors. Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings. Ravi G; Lee K; Ji X; Kim HS; Soltysiak KA; Marquez VE; Jacobson KA Bioorg Med Chem Lett; 2001 Sep; 11(17):2295-300. PubMed ID: 11527718 [TBL] [Abstract][Full Text] [Related]
3. Structurally related nucleotides as selective agonists and antagonists at P2Y1 receptors. Jacobson KA; Moro S; Hoffmann C; Kim YC; Kim HS; Ravi RG; Harden TK; Boyer JL Farmaco; 2001; 56(1-2):71-5. PubMed ID: 11347970 [TBL] [Abstract][Full Text] [Related]
4. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors. Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592 [TBL] [Abstract][Full Text] [Related]
5. Agonists and antagonists for P2 receptors. Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands. Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151 [TBL] [Abstract][Full Text] [Related]
7. Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor. Houston D; Costanzi S; Jacobson KA; Harden TK Comb Chem High Throughput Screen; 2008 Jul; 11(6):410-9. PubMed ID: 18673269 [TBL] [Abstract][Full Text] [Related]
8. Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors. Jacobson KA; Costanzi S; Kim SK; Roh E; Joshi BV; Tchilibon S; Duong HT; Gao ZG Nucleosides Nucleotides Nucleic Acids; 2006; 25(12):1425-36. PubMed ID: 17067963 [TBL] [Abstract][Full Text] [Related]
10. Nomenclature and classification of purinoceptors. Fredholm BB; Abbracchio MP; Burnstock G; Daly JW; Harden TK; Jacobson KA; Leff P; Williams M Pharmacol Rev; 1994 Jun; 46(2):143-56. PubMed ID: 7938164 [No Abstract] [Full Text] [Related]
11. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines. Morrone FB; Jacques-Silva MC; Horn AP; Bernardi A; Schwartsmann G; Rodnight R; Lenz G J Neurooncol; 2003 Sep; 64(3):211-8. PubMed ID: 14558596 [TBL] [Abstract][Full Text] [Related]
12. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary. Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926 [TBL] [Abstract][Full Text] [Related]
13. Nucleotide coronary vasodilation in guinea pig hearts. Gorman MW; Ogimoto K; Savage MV; Jacobson KA; Feigl EO Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1040-7. PubMed ID: 12763753 [TBL] [Abstract][Full Text] [Related]
14. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. Moro S; Guo D; Camaioni E; Boyer JL; Harden TK; Jacobson KA J Med Chem; 1998 Apr; 41(9):1456-66. PubMed ID: 9554879 [TBL] [Abstract][Full Text] [Related]
15. Adenosine receptor ligands: where are we, and where are we going? Tuccinardi T; Martinelli A Curr Top Med Chem; 2010; 10(10):941. PubMed ID: 20681944 [No Abstract] [Full Text] [Related]
16. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets. Jacobson KA; IJzerman AP; Müller CE Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128 [TBL] [Abstract][Full Text] [Related]
17. Purine and pyrimidine receptors. Burnstock G Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261 [TBL] [Abstract][Full Text] [Related]
18. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist. Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631 [TBL] [Abstract][Full Text] [Related]
20. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]